Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Danson

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Journal of Bone Oncology|November 1, 2019
An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone painSarah Danson, Matthew R Mulvey, Lesley Turner, et al.
Heliyon|February 22, 2023
Mental health burden for NHS healthcare staff during the COVID-19 pandemic: First results of a longitudinal surveySarah Danson, Fuschia Sirois, Kathryn Fradley, et al.
Eclinicalmedicine|August 22, 2022
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trialDean A Fennell, Catharine Porter, Jason Lester, et al.
Heliyon|June 19, 2025
Corrigendum to "Mental health burden for NHS healthcare staff during the COVID-19 pandemic: First results of a longitudinal survey" [Heliyon Volume 9, Issue 3, March 2023, Article e13765]Sarah Danson, Fuschia Sirois, Kathryn Fradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Preclinical evaluation of the pharmacodynamic properties of 2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinoneTimothy H Ward, Sarah Danson, Alan T McGown, et al.
Journal of Clinical Pharmacology|July 3, 2002
Pharmacokinetics of histamine dihydrochloride in healthy volunteers and cancer patients: implications for combined immunotherapy with interleukin-2Mark Middleton, Mark Sarno, Sanjiv S Agarwala, et al.
Clinical Trials (London, England)|October 27, 2025
Electronic patient-reported adverse event monitoring in academic early-phase clinical trials: A feasibility studyLeanne Shearsmith, Sarah Danson, Sarah Gelcich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib TrialDean A Fennell, Sarah Danson, Penella J Woll, et al.
BMC Palliative Care|June 13, 2026
Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort studyCatriona R Mayland, Michelle Collinson, Sam H Ahmedzai, et al.
BJS Open|May 29, 2026
Cancer vaccines: comprehensive reviewRachael E Clifford, Nichola Manu, Qian Yang, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Journal of Bone Oncology|November 1, 2019
An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone painSarah Danson, Matthew R Mulvey, Lesley Turner, et al.
Heliyon|February 22, 2023
Mental health burden for NHS healthcare staff during the COVID-19 pandemic: First results of a longitudinal surveySarah Danson, Fuschia Sirois, Kathryn Fradley, et al.
Eclinicalmedicine|August 22, 2022
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trialDean A Fennell, Catharine Porter, Jason Lester, et al.
Heliyon|June 19, 2025
Corrigendum to "Mental health burden for NHS healthcare staff during the COVID-19 pandemic: First results of a longitudinal survey" [Heliyon Volume 9, Issue 3, March 2023, Article e13765]Sarah Danson, Fuschia Sirois, Kathryn Fradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Preclinical evaluation of the pharmacodynamic properties of 2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinoneTimothy H Ward, Sarah Danson, Alan T McGown, et al.
Journal of Clinical Pharmacology|July 3, 2002
Pharmacokinetics of histamine dihydrochloride in healthy volunteers and cancer patients: implications for combined immunotherapy with interleukin-2Mark Middleton, Mark Sarno, Sanjiv S Agarwala, et al.
Clinical Trials (London, England)|October 27, 2025
Electronic patient-reported adverse event monitoring in academic early-phase clinical trials: A feasibility studyLeanne Shearsmith, Sarah Danson, Sarah Gelcich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib TrialDean A Fennell, Sarah Danson, Penella J Woll, et al.
BMC Palliative Care|June 13, 2026
Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort studyCatriona R Mayland, Michelle Collinson, Sam H Ahmedzai, et al.
BJS Open|May 29, 2026
Cancer vaccines: comprehensive reviewRachael E Clifford, Nichola Manu, Qian Yang, et al.
Pageof 7